MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Turn Therapeutics Inc. (TTRX)

Turn Therapeutics Inc. (TTRX)

|||

Balance Sheets Overview

Current Ratio
118.99%
Quick Ratio
118.99%
Debt to Asset Ratio
95.95%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Deferred offering cost
    • Intangible assets, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Derivative liability instrument
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
10,288,510
11,217,671
5,076,144
3,106,157
Prepaid expenses and other current assets
139,688
235,171
120,300
188,583
Total current assets
10,428,198
11,452,842
5,196,444
3,294,740
Right-of-use asset
56,275
67,573
78,620
89,423
Intangible assets, net
911,219
919,947
922,171
904,885
Deferred offering cost
5,556,445
6,195,192
5,956,424
-
Security deposit
8,582
8,582
8,582
8,582
Total assets
16,960,719
18,644,136
12,162,241
4,297,630
Accounts payable and accrued expenses
2,605,752
2,315,265
2,928,728
2,264,425
Derivative liability instrument
6,109,030
2,767,462
3,028,401
-
Current portion of operating lease liability
49,329
47,795
46,295
44,829
Total current liabilities
8,764,111
5,130,522
6,003,424
2,309,254
Operating lease liability, net of current portion
8,713
21,539
34,081
46,344
Long-term debt, net
6,062,994
5,936,514
-
-
Deferred revenue
1,438,013
1,438,013
1,438,013
1,438,013
Total liabilities
16,273,831
12,526,588
7,475,518
3,793,611
Common stock, 0.0001 par value, 500 million shares authorized at june 30, 2026 and december 31, 2025 29,788,040 and 29,445,183 shares issued at june 30, 2026 and december 31, 2025, respectively
2,977
2,977
2,943
2,802
Additional paid-in capital
29,894,869
29,475,636
28,143,873
23,223,079
Subscription receivable
-
-
1,070,000
52,699
Accumulated deficit
-29,210,958
-23,361,065
-22,390,093
-22,669,163
Total stockholders equity
686,888
6,117,548
4,686,723
504,019
Total liabilities and stockholders equity
16,960,719
18,644,136
12,162,241
4,297,630
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$10,288,510 Prepaid expenses andother current assets$139,688 Total current assets$10,428,198 Deferred offering cost$5,556,445 Intangible assets, net$911,219 Right-of-use asset$56,275 Security deposit$8,582 Total assets$16,960,719 Total liabilities andstockholders equity$16,960,719 Total liabilities$16,273,831 Total stockholdersequity$686,888 Accumulated deficit-$29,210,958 Total currentliabilities$8,764,111 Long-term debt, net$6,062,994 Deferred revenue$1,438,013 Operating leaseliability, net of current...$8,713 Additional paid-in capital$29,894,869 Common stock, 0.0001par value, 500...$2,977 Derivative liabilityinstrument$6,109,030 Accounts payable andaccrued expenses$2,605,752 Current portion ofoperating lease liability$49,329